Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan ...Middle East

VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). H. Lundbeck A/S...

Hence then, the article about lundbeck s potential treatment for multiple system atrophy granted orphan drug designation in japan was published today ( Monday 10/03/2025 - 11:33 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan )

Also on site :

• GCE Global Solutions Corp. Announces Strategic Acquisition of GCE Payroll Advisers Inc. to Strengthen Global EOR and Payroll Platform
• Trump Wants To”Unleash Hell” In 2026; POTUS Tries To Go Full Maximus With A Misguided ‘Gladiator’ Flex
• Mickey Rourke Sued for $59,100 in Unpaid Rent, Facing Eviction